Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - A randomized double blind pilot trial

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 14, 2012, Pages 1989-1993

  Canpolat, F ^a   Erkocoglu M ^b   Tezer, H ^b   Kocabas C N ^b   Kandi, B ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA ONCOLOGY HOSPITAL   (Turkey)

Author keywords

Atopic dermatitis; Hydrocortisone ointment; Infants; Mupirocin; Staphylococcus

Indexed keywords

HYDROCORTISONE ACETATE; PSEUDOMONIC ACID;

ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECZEMA AREA AND SEVERITY INDEX; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MONOTHERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OINTMENT; PILOT STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SEVERITY SCORING OF ATOPIC DERMATITIS INDEX; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EMOLLIENTS; HUMANS; HYDROCORTISONE; INFANT; MUPIROCIN; OINTMENTS; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 84874102610     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. AKDIS CA, AKDIS M, BIEBER T., BINDSLEV-JENSEN C, BOGUNIEWICZ M, EIGENMANN P., HAMID Q, KAPP A, LEUNG D Y, LIPOZENCIC J, LUGER T.A., MURARO A., NOVAK N, PLATTS-MILLS TA, ROSENWASSER L, SCHEYNIUS A., SIMONS FE, SPERGEL J, TURJANMAA K, WAHN U, WEIDINGER S, WERFEL T, ZUBERBIER T; EUROPEAN ACADEMY OF ALLERGOLOGY; CLINICAL IMMUNOLOGY/AMERICAN ACADEMY OF ALLERGY, ASTHMA AND IMMUNOLOGY/PRACTALL CONSENSUS GROUP. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006; 61: 969-987.
2. ILLI S, VON MUTIUS E, LAU S, NICKEL R., GRUBER C, NIGGEMANN B, WAHN U; MULTICENTER ALLERGY STUDY GROUP. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004; 113: 925-931.
3. Darsow U, Lubbe J, Taieb A., Seidenari S, Wollenberg A, Calza A.m., Giusti F., Ring J; EUROPEAN TASK FORCE ON ATOPIC DERMATITIS. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005; 19: 286-295.
4. HANIFIN JM, COOPER KD, HO V.C., KANG S., KRAFCHIK BR, MARGOLIS DJ, SCHACHNER LA, SIDBURY R, WHITMORE S.E., SIECK CK, VAN VOORHEES AS. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association Administrative Regulations for Evidence-Based Clinical Practice Guidelines. J Am Acad Dermatol 2004; 50: 391-404.
5. Stalder J.F., Fleury M, Sourisse M., Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994; 131: 536-540.
6. NILSSON EJ, HENNING CG, MAGNUSSON J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29-34.
7. BREUER K, KAPP A, WERFEL T. Bacterial infections and atopic dermatitis. Allergy 2001; 56: 1034-1041.
8. BREUER K, HAUSSLER S, KAPP A., WERFEL T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002; 147: 55-61.
9. LEUNG DY. Infection in atopic dermatitis. Curr Opin Pediatr 2003; 15: 399-404.
10. HANIFIN JM, RAJKA G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl 1980; 92: 44-47.
11. RAJKA G, LANGELAND T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl 1989; 144: 13-14.
12. PUCCI N, LOMBARDI E, NOVEMBRE E., FARINA S, BERNARDINI R, ROSSI M.E., FAVILLI T., VIERUCCI A. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol 2000; 105: 353-357.
13. HANIFIN JM, THURSTON M, OMOTO M., CHERILL R, TOFTE SJ, GRAEBER M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001; 10: 11-18.
14. http://www.dssresearch.com/toolkit/spcalc/power-a2.asp
15. HIGAKI S, MOROHASI M, YAMAGISHI T., HASEGAWA Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol 1999; 38: 265-269.
16. LEVER R, HADLEY K, DOWNEY D., MACKIE R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988; 119: 189-198.
17. RAVENSCROFT JC, LAYTON AM, EADY E.A., MURTAGH MS, COATES P, WALKER M, COVE JH Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 2003; 148: 1010-1017.
18. Gong JQ, Lin L, Lin T., Hao F, Zeng FQ, Bi Z.G., Yi D., Zhao B. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006; 155: 680-687.
19. HUNG SH, LIN YT, CHU C.Y., LEE CC, LIANG TC, YANG YH, WANG L.C., CHIANG BL Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol 2007; 98: 51-56.
20. Brockow K, Grabenhorst P, Abeck D., Traupe B, Ring J, Hoppe U., Wolf F. Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus aureus-colonized atopic eczema. Dermatology 1999; 199: 231-236.
21. WENDT C, SCHINKE S, WURTTEMBERGER M., OBERDORFER K, BOCK-HENSLEY O, VON BAUM H. Value of wholebody washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, doubleblind clinical trial. Infect Control Hosp Epidemiol 2007; 28: 1036-1043.
22. NILSSON EJ, HENNING CG, MAGNUSSON J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29-34.
23. STALDER J.F., FLEURY M, SOURISSE M., ROSTIN M, PHELINE F, LITOUX P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994; 131: 536-540.
24. POURNARAS CC, LUBBE J, SAURAT JH Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (FK506). J Invest Dermatol 2001; 116: 480-481.
25. GAUGER A, MEMPEL M, SCHEKATZ A., SHAFER T, RING J, ABECK D. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 2003; 207: 15-21.
26. YOSHIMURA-MISHIMA M., AKAMATSU H, NAMURA S., HORIO T. Suppressive effect of ultraviolet (UVB and PUVA) radiation on superantigen production by Staphylococcus aureus. J Dermatol Sci 1999; 19: 31-36.
27. HUANG JT, ABRAMS M, TLOUGAN B., RADEMAKER A, PALLER AS Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123: e808-e814.